
Fever Labs Inc.
New York-headquartered live entertainment technology company behind the Fever platform and Candlelight concerts, valued at $1.8 billion.
Company Type
private
Founded
2014
Headquarters
New York City, New York, USA
Revenue
Not publicly disclosed (EBITDA profitable since 2024)
Employees
More than 1,000
Primary Market
Global
Shop Fever Labs Inc. Brands
Disclosure: We may earn commission from purchasesAbout Fever Labs Inc.
Who owns Fever Labs?
The company is owned by its four co-founders and institutional investors including Goldman Sachs, Eurazeo, L Catterton, Point72, EQT, Baillie Gifford, Accel, and others. No single controlling shareholder is disclosed.
Is Fever Labs publicly traded?
No. It remains private at a $1.8 billion valuation, though company statements have referenced a potential future IPO.
When was Fever founded?
Fever was founded in 2014 in Madrid, Spain, and is now headquartered in New York City.
How much has Fever raised?
Approximately $790 million across rounds, including $227 million led by Goldman Sachs in 2022, $110 million in 2023, $100 million-plus in June 2025, and $250 million in September 2026.
Is Fever profitable?
The company reported full-year EBITDA profitability in 2024 alongside 20-fold revenue growth versus pre-pandemic levels. No audited public financials are available.
History of Fever Labs Inc.
The four co-founders started Fever in Madrid in 2014. Ignacio Bachiller Strohlein, now CEO, had an offer from McKinsey when he and Pep Gomez, Francisco Hein, and Alexandre Perez Casares began building what they described as a Netflix-style destination for live events.
Early funding included angel capital and a 2014 seed round, followed by Series A and B backing from Accel, Fidelity, and 14W. European investors including Rakuten, Atresmedia (in a media-for-equity deal), Mangrove, and Portugal Ventures financed the platform's spread into a discovery product covering dozens of cities and languages.
Two strategic additions changed the company's trajectory. The Secret Media Network built local media audiences that funneled readers toward bookings. Then, from 2019, Fever Originals launched proprietary formats it owns outright, with Candlelight, intimate classical concerts staged in candlelit venues, becoming a global phenomenon running in hundreds of cities.
The pandemic recovery supercharged the model. In January 2022 Goldman Sachs led a $227 million round at a valuation just above $1 billion, earmarked toward a possible IPO path the company discussed publicly. A $110 million round in January 2023 from investors including Eurazeo, Goodwater Capital, and Alignment Growth set the $1.8 billion valuation that still stands.
Recent history centers on music and sports expansion. The platform now serves independent promoters like TCE Presents, Cercle Music, and Last Tour, venues including Clapham Grand and Brooklyn Storehouse, and festivals such as Primavera Sound and Pitchfork Music Festival, while ticketing sports properties including Real Madrid, FC Barcelona, LIV Golf, and the X Games. New capital arrived in June 2025, $100 million-plus from L Catterton and Point72 Private Investments, and September 2026, $250 million from investors including EQT, Baillie Gifford, and Point72 Ventures.
Brands Owned by Fever Labs Inc.
Fever Labs Inc. owns 1 brand in our database. Explore the ownership tree below — click categories to expand and see individual brands.
Fever Labs Inc.
private · Founded 2014 · New York City, New York, USA
1
brands
Fever Labs Inc. Ownership: Pros & Cons
Advantages
- +Deeply funded with roughly $790 million raised from top-tier growth investors
- +Owned formats deliver margin independent of ticketing fee compression
- +Media plus data flywheel improves both discovery and event economics
- +Reported EBITDA profitability provides self-funding capacity
Considerations
- -Valuation has been flat since 2023 despite new capital, implying growth-priced expectations
- -Entrenched rivals, especially Live Nation, dominate venue and promoter relationships
- -Content-driven hit risk: Originals must be continually reinvented
- -Opaque private financials limit external scrutiny of profitability claims
Frequently Asked Questions About Fever Labs Inc.
Who owns Fever Labs?
The company is owned by its four co-founders and institutional investors including Goldman Sachs, Eurazeo, L Catterton, Point72, EQT, Baillie Gifford, Accel, and others. No single controlling shareholder is disclosed.
Is Fever Labs publicly traded?
No. It remains private at a $1.8 billion valuation, though company statements have referenced a potential future IPO.
When was Fever founded?
Fever was founded in 2014 in Madrid, Spain, and is now headquartered in New York City.
How much has Fever raised?
Approximately $790 million across rounds, including $227 million led by Goldman Sachs in 2022, $110 million in 2023, $100 million-plus in June 2025, and $250 million in September 2026.
Is Fever profitable?
The company reported full-year EBITDA profitability in 2024 alongside 20-fold revenue growth versus pre-pandemic levels. No audited public financials are available.





